Tyrosine kinase inhibitors (TKI): agents

Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .

Tyrosine kinase inhibitors (TKI): agents. Alectinib, Brigatinib, Ensartinib. Fully referenced neurology checklist.

ALK inhibitors

  • Alectinib
  • Brigatinib
  • Ensartinib

BTK inhibitors

Locked: subscribe to see this section.

EGFR inhibitors

Locked: subscribe to see this section.

FGFR inhibitors

Locked: subscribe to see this section.

HER2 inhibitors

Locked: subscribe to see this section.

JAK 1 and 2 inhibitors

Locked: subscribe to see this section.

KIT inhibitors

Locked: subscribe to see this section.

MEK inhibitors

Locked: subscribe to see this section.

MET inhibitors

Locked: subscribe to see this section.

RET inhibitors

Locked: subscribe to see this section.

SRC inhibitors

Locked: subscribe to see this section.

TRK inhibitors

Locked: subscribe to see this section.

VEGFR inhibitors

Locked: subscribe to see this section.

Multi-target inhibitors

Locked: subscribe to see this section.

References

  1. Jiao Q, Bi L, Ren Y, Song S, Wang Q, Wang YS. Advances in studies of tyrosine kinase inhibitors and their acquired resistance. Mol Cancer 2018; 17:36.
  2. Huang L, Jiang S, Shi Y. Tyrosine kinase inhibitors for solid tumors in the past 20 years (2001-2020). J Hematol Oncol 2020; 13:143.

Related checklists

Loading...